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HUMAN  C4-BINDING  PROTEIN 
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(From the Department of  Pathology, the Department of  Dermatology and Irvington House, New 
York University School of Medicine, New York 10016) 
Human  C4  and  mouse  Ss  proteins  show  extensive  structural  homologies. 
They are antigenically related (1) and are composed of three polypeptide chains 
of similar molecular weights,  linked by disulfide bonds (2, 3). In addition,  it is 
very likely that the major histocompatibility complex of these species contains 
structural genes for beth proteins  (3-5).  However,  some functional differences 
between the Ss protein and the C4 hemolytic activity of mouse serum have been 
reported (6). 
We recently described a new protein in mouse serum which forms complexes 
with  the  Ss protein,  and  also  with  C4 of human or guinea  pig origin  (7,  8). 
Because of the remarkable specificity of its interaction with Ss (C4) we named 
this  protein  Ss-  or  C4-binding  protein,  and  suggested  it ~might  be  a  new 
complement  component.  This  question  could  not  be  appropriately  studied  in 
mouse serum, whose complement system is still poorly characterized.  Therefore 
we  approached  the  problem  by  searching  for  a  C4-binding  protein  (C4-bp)' 
analogue in human serum. 
In this paper we report the isolation and characterization  of a human serum 
protein that differs from all known complement components, which has proper- 
ties very similar to those of mouse C4-bp. 
Materials and Methods 
Materials.  Dimethyl suberimidate, Aldrich Chemical Co.,  Inc., Milwaukee, Wis.; agarose 
and human transferrin, Behring Diagnostics, American Hoechst  Corp.,  Sommerville, N.  J.; 
Biorex 70, N,N'-methylene-bis-acrylamide,  acrylamide, N,N,N',N'-tetramethylethylenediamine, 
ammonium persulfate, sodium dodecyl  sulfate (SDS), Bio-Rad Laboratories, Richmond, Calif.; 
diisopropylfluorophosphate  (DFP),  Calbiochem,  San Diego, Calif.; sucrose,  Fisher Scientific Co., 
* Supported by grants AI-08499, AI-13809, AI-13224, and CA 16247 from the National Institutes 
of Health:  presented in part at the International Complement Workshop,  Florida, November, 
1977; part of J. Scharfstein's PhD dissertation in the Graduate School of Arts and Science, New 
York University School of Medicine. 
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1  Abbreviations  used  in this paper:  BSA, bovine serum albumin; C4-bp, C4-binding protein; 
C4D, serum from a patient genetically deficient in C4; CIE, crossed immunoelectrophoresis;  DFP, 
diisopropylfluorophosphate;  DGVB, isotonic veronal buffer containing  glucose and gelatin; OVA, 
ovalbumin; PBS, phosphate-buffered saline; PEG, polyethylene glycol; RIE, rocket immunoelec- 
trophoresis;  SDS-PAGE, sodium dodecylsulfate polyacrylamide gel electrophoresis;  Tf, transfer- 
rin. 
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Pittsburgh,  Pa.; bovine serum albumin (BSA), Miles Research Laboratories, Inc., Kankakee, Ill.; 
Staphylococcus  A  (IgGsorb),  New  England  Enzyme  Center,  Tufts  University,  Boston,  Mass.; 
Nonidet P-40 (NP-40),  Shell Chemicals Co., London, England; polyethyleneglycol mol wt 4,000, 
e-aminocaproic acid,  ovalbumin,  ~-galactosidase  (Escherichia  coli),  catalase  (beef liver), myo- 
globin  (horse  heart),  alcohol  dehydrogenase  (yeast),  phosphorylase  a  (rabbit  muscle),  Sigma 
Chemical Co.,  St.  Louis,  Mo.; bovine thrombin,  Parke,  Davis and Co.,  Detroit,  Mich.; DEAE 
Sephadex  A-50,  CNBr-activated  Sepharose  4B,  Pharmacia  Fine  Chemicals,  Inc.,  Piscataway, 
N. J.; heparin  (liquaemin sodium),  Organon,  Inc.,  W.  Orange,  N. J.; DEAE-cellulose (DE-52), 
Whatman Ltd., Springfield Mill, Maidstone, Kent, England; fuchsin sulfite, Harleco, Gibbstown, 
N. J. IgG, IgM, human myeloma proteins, and  a2-macroglobulin were gifts of Dr. E. Franklin, 
New York University School of Medicine, New York. 
Diluents.  Isotonic veronal-buffered saline,  pH 7.4,  ionic strength  0.145  M, containing 0.1% 
gelatin, 1.5 ×  10 -4 M CaC12 and 5 x  10  -5 M MgC1 (GVB++), dextrose veronal-buffered saline ionic 
strength  0.075  M  (DGVB  ++) and 2  ×  10  -3 M disodium EDTA were prepared  according to usual 
procedures  (9).  Barbital-EDTA, buffer pH 8.6,  containing 23 mM sodium barbital,  3.7 mM bar- 
bituric acid, and 2 mM EDTA. Phosphate-buffered saline (PBS) was from Grand Island Biological 
Co., Grand Island, N. Y. 
Purified Complement Components and Reagents.  Ci and C4 were purified to homogeneity as 
described (10, 11). C4 had a specific activity 140 times higher than in the original plasma. In 5.6% 
SDS polyacrylamide  gel electrophoresis  (PAGE),  under  nonreducing  conditions,  C4  showed  a 
single band with an apparent mol wt of 200,000 and after reduction, the characteristic a,/~, and 
chains were observed. C4b was prepared by adding 10 #ag of Ci to 400/~g of C4, and incubating the 
mixture  for  18 h  at 4°C.  Cleavage of the  a-chain of C4 was  ascertained  by SDS-PAGE under 
reducing conditions  and  by  loss of hemolytic activity.  Pure  C3  was  a  gift from  Dr.  B.  Tack, 
National  Institutes  of Health,  Bethesda,  Md.  Sera  from  patients  with  C4  deficiency and  C3b 
inactivator  deficiency were  gifts  from  Doctors  H.  Ochs,  University of Washington  School  of 
Medicine, Seattle, Wash.,  and C. Alper, Harvard University School of Medicine, Boston, Mass., 
respectively. 
Sepharose-4B coupled to C4b was prepared as described in (12). 
Antisera.  Rabbit  anti-human  C4,  C3,  IgG,  Clq,  Cls,  Cls inactivator,  Behring  Diagnostics, 
American Hoechst Corp.; goat anti-human C4, Meloy Laboratories Inc., Springfield, Va.; Rabbit 
anti-transferrin (IgG fraction), Dako Laboratories, Copenhagen, Denmark; goat anti-IgM, Cappel 
Laboratories,  Inc.,  Cochranville,  Pa.;  rabbit  anti-a-2  macroglobulin,  Bio-Rad  Laboratories, 
antiserum to C3b-inactivator, Kent Laboratories,  North Vancouver; British Columbia; anti-Clr 
was  a  gift from Dr.  R.  R.  Porter.  Anti-B1H was a  gift from Doctors C.  Alper and  D.  Fearon, 
Harvard  University School of Medicine,  Boston,  Mass.  Anti-high molecular weight kininogen 
was a  gift from Dr. J.  V.  Pierce, National Institutes of Health,  Bethesda,  Md. Anti-ovalbumin 
was  a  gift from  Dr.  Z.  Ovary,  New York University School of Medicine,  New York.  The IgG 
fraction of the goat antiserum to C4 was prepared by chromatography on DEAE-cellulose. 
Preparation  of Antiserum to Human C4-bp.  Fresh human serum (1.2 ml) was incubated with 
1.5  mg  of  ovalbumin  (OVA)  anti-OVA  immune  precipitates  prepared  at  equivalence  and 
suspended in 0.6 ml of DGVB ++ buffer. The mixture was incubated for 10 min at 37°C, then 0.2 ml 
of 0.1 M Na~H EDTA, pH 7.6 was added, followed by centrifugation at 1,000g for 10 min. 0.4 ml of 
the supernate was mixed with 0.3 ml of an IgG fraction of a goat antiserum to C4. After incubation 
at 37°C for 30 min, the mixture was spun down; the supernate was further treated with a second 
aliquot of the goat antiserum to C4, and the cycle repeated until precipitation ceased to occur. The 
precipitated material was pooled, washed five times with DGVB-EDTA, dispersed with the aid of 
a syringe and needle, and resuspended in 1.5 ml of 0.15 M NaC1. This was emulsified in complete 
Freund's adjuvant and injected in the four footpads of two 5- to 6-mo-old female rabbits. Bleedings 
were started on day 21. By crossed immunoelectrophoresis, using whole human serum as antigen, 
beth antisera contained only antibodies to C4 and to C4-bp. The antisera were made monospecific 
by absorption with Sepharose 4B-C4b. 
Analytical Procedures: Immunoelectrophoresis.  Crossed (CIE) and rocket (RIE) immunoelec- 
trophoresis were run as described (13-15).  For CIE, the electrophoresis in the first dimension was 
performed at 10 V/cm at 10°C. When necessary,  human transferrin was mixed with the antigen 
studied  to serve as an internal  marker.  RIE was run at 2 V/cm at 10°C for 16 h.  The levels of 
antigen  were  evaluated  by  measurement  of the  peak  heights  after  staining.  At  least  three J.  SCHARFSTEIN,  A.  FERREIRA,  I.  GIGLI,  AND  V.  NUSSENZWEIG  209 
dilutions of standards  were included in each slide to estimate the relative concentration of the 
unknowns. 
Polyacrylamide Gel Electrophoresis.  Slab gel polyacrylamide electrophoresis was performed 
as described by Laemmli (16). The stacking and separating gel combinations used were either 3 
and 5% or 3 and 7.5%. Disc gel electrophoresis was carried out as described previously (17) in 3.5% 
polyacrylamide gels. 
To oalibrate the gels for molecular weight estimations under reducing conditions, the following 
protein markers  were used:  B-galactosidase  (130,000),  phosphorylase A  (94,000),  BSA (68,000), 
yeast alcohol dehydrogenase (37,000),  and catalase (60,000). 
As standards for the determination of the molecular weight of C4-bp in its unreduced form, we 
prepared  a  mixture of multimeric IgG by a  modification of a  previously described cross-linking 
procedure (18, 19). In a typical protocol, 25/~1 of 1.2 mg/ml dimethyl suberimidate was mixed with 
0.2 ml of 5-10 mg/ml of specifically purified (anti-dinitrophenol) rabbit IgG in 0.2 M Tris pH 8.5. 
To this mixture we immediately added 0.2 ml of 2% SDS in the same buffer. The samples were 
then frozen in ethanol-dry ice, the mixtures stored at -10°C for 24 h and incubated at 37°C for 2 h 
before treatment  with 2% SDS-6 M  urea and electrophoresis.  In most cases four to five dense 
bands were obtained, corresponding to the monomeric and di, tri, tetrameric forms of IgG. In a 
similar way we obtained oligomeric forms of BSA. Gels were stained for carbohydrate content by 
the periodic acid-Schifftechnique (20). 
Sucrose Gradient Ultracentrifugation.  0.2 ml of protein samples were loaded on top of 5-ml 
tubes  containing  linear  10-40%  sucrose  gradients  in  DGVB-EDTA.  Ultracentrifugation  was 
carried out at 38,000 rpm for 20 h at 4°C using a SW50.1 rotor. The positions of a2-macroglobulin, 
IgM, C3, C4-bp, and transferrin in serum were determined by RIE, while IgG was monitored by 
radial  immunodiffusion.  When  purified  C4-bp  was  subjected  to  ultracentrifugation,  purified 
human  C3,  a2-macroglobulin,  myeloma IgG,  and  radiolabeled  BSA were added to the sample 
immediately before the run.  These  proteins  served as  standards  for the determination  of the 
sedimentation coefficient of C4-bp. 
Radiolabeling of C4-bp.  This was performed according to a  modification of the Hunter and 
Greenwood method  (21): 50  /~l of 0.8 M  Tris-HC1,  pH 7.5 was added  to 2 mCi of ~25I, aqueous 
solution, New England Nuclear, Boston, Mass., followed by 200/~l of purified C4-bp at 0.35 OD/ml 
and 25 ~l of chloramine-T (0.5 mg/ml). The mixture was incubated for 5 min, and 25 ~1 of sodium 
metabisulfite  (0.5  mg/ml), followed by 0.2 ml PBS,  were added  to terminate  the reaction.  All 
reagents were kept in ice. The labeled protein was dialyzed for 48 h against PBS. After removal 
from the dialysis bag, 2 mg of BSA in 0.1 ml of PBS were added to the sample. 
Immunoprecipitation of ~25I-C4-bp/Anti-C4-bp Complexes.  This was performed as described by 
Kessler (22) using a  suspension of formaldehyde-treated  Staphylococcus A  (Cowan I strain).  ~25I 
C4-bp was treated with increasing volumes of rabbit antiserum to C4-bp or normal rabbit serum. 
The samples were incubated for 20 min at room temperature, then 50 ~1 at 10% Staphylococcus A 
suspension were added and the mixture incubated for an additional 20 min at room temperature. 
The  tubes  were  centrifuged  at  2,000  g  for  20  min,  and  the  pellets  washed  several  times  by 
centrifugation. After counting the radioactivity associated with the pellets, 150 ~1 of 2% SDS-6 M 
urea was added and the suspension was heated for 3 min in boiling water vapors. The bacteria 
were  removed by centrifugation,  the supernates  were counted,  and  recoveries estimated.  The 
eluates  were  loaded  in  SDS-PAGE  slabs  under  nonreducing  or  reducing  conditions.  After 
electrophoresis the gels were dried and radioautographed  for 2-24 h  by using Kodak X-omat R 
film (Eastman Kodak Co., Rochester, N. Y.). 
Affinity Chromatography of ~25I-C4-bp.  This was done by incubating ~2sI-C4-bp in 0.01 M Tris, 
0.025  M NaC1, pH 8.6,  with increasing vol of a 25% suspension of Sepharose 4B-C4b or Sepharose 
4B-BSA for 30 min at 37°C. The beads were extensively washed in the same buffer. The material 
bound  to the beads  was  eluted  by treatment  with  2%  SDS-6 M  urea  for 3  min  at  100°C and 
analyzed on SDS-PAGE slabs, followed by radioautography. 
Results 
Interaction  between  C4-Binding  Protein  and  C4  in  Human  Serum.  The 
formation  of complexes  between  an activated  form of C4 and C4-binding  protein 
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Fro.  1.  CIE  in  1%  agarose,  EDTA-barbital buffer, of serum and  EDTA-plasma.  After 
subjecting the  plasma  or  serum  to  electrophoresis in  the  first  dimension,  the  second 
dimension was performed in the presence of either antiserum to C4-bp (top slides) or to C4 
(bottom slides). An antiserum to transferrin was added to all slides. The transferrin peak 
serves as an internal marker (Tf). 
develop CIE of samples of human serum and EDTA-plasma. 
After  CIE  of EDTA-plasma  (Fig.  1,  top  right)  C4-bp  moves  as  a  slow  fl- 
globulin.  However, in serum  (top left) under the same conditions,  the position 
of the C4-bp peak shifts markedly toward the anode and is asymmetric,  with 
some trailing toward the cathode (transferrin serves as an internal marker). 
C4 patterns  in the same samples are shown below. While in EDTA-plasma 
(Fig.  1, bottom right)  C4 appears as a  homogeneous peak which has the same 
mobility as purified C4, in serum C4 shows a bimodal distribution.  The slower 
part of the C4 peak has an electrophoretic mobility similar to that of native C4 
while  the  fast  portion  of the  C4-peak  coincides  with  the  position  of C4-bp. 
Although  the  ratios  between slow versus fast  C4  varied  in  different  runs  of 
various sera,  in all experiments  the C4-bp peak was shifted in relation  to its 
position in EDTA-plasma,  and its position always coincided with the position of 
the fast C4 peak. 
The bimodal distribution of C4, as well as the anodal displacement of C4-bp, 
reflects  the  activation  of the  complement  system  during  electrophoresis  in 
agarose  and  the  binding  of activated  C4  to  C4-bp.  The  activation  of C1  and J.  SCHARFSTEIN, A.  FEI~REIRA~ I.  GIGL]~ AND  V.  NUSSENZWEIG  211 
Fro.  2.  Formation of activated C4/C4-bp complexes in serum. Samples of undiluted fresh 
human serum were subjected to CIE. The first dimension of electrophoresis was run in the 
presence of antisera  to C4 (plate C), C3 (plate B), or normal rabbit  serum  (plate A). The 
second  dimension  was  always  performed  in  the  presence  of an  oligo-specific rabbit 
antiserum  containing antibodies to C4-bp and C4. In plate A, C4 and C4-bp migrate as fast 
E-globulins and their peaks overlap. In plate C, the presence of an antiserum  monospecific 
to  C4  during  the  first  dimension  completely abrogated  both  C4  and  C4-bp peaks.  In 
contrast,  in plate B, the C4-bp and C4 peaks are not modified although a heavy C3 anti-C3 
precipitate formed during electrophoresis in the first dimension. 
proteolysis  of C4  after  contact  of serum  with  agarose  have  previously  been 
reported  (23),  and can be prevented by chelation of divalent cations.  If 10 mM 
EDTA were added to serum before CIE, C4 and C4-bp showed profiles identical 
to  those  in  EDTA-plasma.  That  activated  C4  and  C4-bp  form  complexes  in 
serum was demonstrated by a  technique  involving a  combination of RIE and 
CIE (Fig.  2).  In the first part of the experiment, human serum was subjected to 
RIE in  the  presence  of a  monospecific rabbit  antiserum  to  C4  (plate  C)  or of 
normal  rabbit  serum  (plate  A).  The plates  were then  subjected to the  second 
electrophoresis  (CIE)  in  agarose containing a  mixture  of antibodies  to  C4-bp 
and  C4.  In plate  C,  the presence of anti-C4 in the first dimension completely 
abrogated both C4 and C4-bp peaks. To rule out the possibility that C4-bp had 
bound nonspecifically to the C4-anti-C4 precipitate formed in the first dimen- 212  HUMAN  C4-BINDING  PROTEIN 
sion, a control plate was included in which an antiserum to C3 (instead of anti- 
C4)  was  added  to  the  agarose.  Although  a  strong  C3-anti-C3  precipitate 
appeared  during  RIE,  the  peaks  of C4 or C4-bp were not  affected  (plate  B), 
when compared to those shown in plate A. 
To analyze the interaction between activated C4 and C4-bp, we proceeded to 
isolate C4-bp. 
Isolation  of C4-Binding  Protein.  C4-bp  was  isolated  from  plasma  by  a 
combination of chromatographic procedures on DEAE-Sephadex, Biorex-70, and 
precipitation  by polyethyleneglycol. The fractionation  of C4-bp was monitored 
by  RIE  using  monospecific  antisera  to  C4-bp  and  to  C4.  All  steps  of the 
fractionation were carried out at 4°C. 
60 ml of 0.1 M EDTA, pH 7.55, was added to 540 ml of fresh acid citrate dex- 
trose plasma. The plasma was stirred in ice and precipitated by drop-wise addi- 
tion  of 300  ml  of 15%  (wt/vol)  of polyethyleneglycol dissolved  in  phosphate- 
buffered saline,  15 mM EDTA, pH 7.55.  ARer 20 min,  the plasma was centri- 
fuged at 10,000 g. The precipitate was resuspended to 600 ml with 0.01 M Tris, 
0.18 M  NaC1,  pH 7.6.  The  insoluble material  was removed by centrifugation, 
and to the supernate we added calcium chloride to 2 mM, 400 U of thrombin, and 
the mixture was incubated at 37°C for 10 min. The resulting clot was liquified in 
a Waring blender for 5 s and centrifuged at 10,000g for 15 min. To the supernate 
we added drop-wise half volume of a 26% solution of polyethyleneglycol made in 
the  same buffer as above.  After 20  min  at  0°C,  the precipitated  fraction  was 
dissolved in 100 ml of a buffer containing 0.01  M Tris, pH 8.6, 0.075 M NaC1, 5 
mM EACA,  and  5 mM EDTA,  centrifuged  to remove insoluble material  and 
loaded on a  2.7 x 35-cm column of DEAE Sephadex A-50 equilibrated with the 
same buffer. The column was washed with the starting buffer until the OD 280 
reached 0.080, and then eluted with 900 ml of a  linear NaC1 gradient  (Fig.  3). 
C4-bp antigen eluted in three major peaks between 8 and 16 mS (at 0°C). The 
first peak,  which did not contain  appreciable  amounts of C4,  was pooled and 
concentrated by precipitation  with one half volume of 26% polyethyleneglycol 
(PEG), as described above. The precipitate was resuspended in 25 ml of 0.02 M 
phosphate  buffer,  pH  7.2,  with  a  conductivity  of 1.8  mS  at  0°C,  cleared  of 
insoluble material by centrifugation,  and applied to a Biorex-70 column (2.5  x 
30  cm)  equilibrated  with the  same buffer.  The  column  was washed with the 
starting  buffer and then  a  linear  NaC1 gradient  was applied.  C4-bp eluted at 
conductivities above 10 mS, as a  heterogeneous peak (Fig.  4,  peaks A, B, and 
C). Peak A contained C4, in addition to C4-bp. Peaks B and C were pooled and 
concentrated to a  vol of 13 ml  ~l~80Cmnm =  0.35).  When analyzed on SDS-PAGE, 
the pooled fractions showed two major bands, which migrated very close to each 
other. These bands were in an identical position to those seen in the individual 
fractions  from the column,  although  the fractions  contained  different propor- 
tions of the two protein bands (Fig. 4). In addition, two minor contaminants of 
lower molecular weight could be seen in the individual fractions as well as in 
the pool. 
That the two major bands in the pooled fractions were C4-bp was shown by 
two independent  criteria:  they bind specifically to C4b, and are recognized by 
the  monospecific antiserum  to  C4-bp,  as shown by the  following experiment. 
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Fro.  3.  Chromatography  on  DEAE-Sephadex.  The  0-5%  polyethyleneglycol  fraction  of 
plasma was recalcifled,  clotted with thrombin, and the clot removed as described in the 
text. The supernate was precipitated with PEG. The precipitate was resuspended in 0.01 M 
Tris,  0.075  M  NaC1,  5 mM EACA,  5 mM EDTA,  pH 8.6,  conductivity 5.2 mS  (0°C)  and 
loaded on a  DEAE-Sephadex A-50 column (2.7 x 35 cm) equilibrated with the same buffer. 
After elution of the pass-through peak, the column was washed and a linear NaC1 gradient 
was  applied.  The  mixing chamber contained  450  ml  of the  starting  buffer,  and  it was 
connected by a  syphon to a  flask containing 450 ml of eluting buffer, the conductivity of 
which was adjusted to 20 mS with NaC1.6-ml fractions were collected at a rate of 20 ml/h. 
C4 and C4-bp were monitored by RIE. 
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FIG.  4.  Biorex-70 chromatography.  The C4-bp pool from  DEAE-Sephadex  chromatogra- 
phy was concentrated by addition of half volume of 26% PEG and resuspended in 25 ml of 
0.02 M phosphate buffer pH 7.2 at a conductivity of 1.8 mS (0°C). The sample was applied to 
a Biorex column (2.5 x 30 cm) equilibrated with the same buffer. After washing, C4-bp was 
eluted with a  linear salt gradient. The mixing chamber contained 400  ml of the starting 
buffer  and  the  second  flask  contained 400  ml  of 0.7  M  NaC1  in  the  same  buffer.  4-ml 
fractions were collected at a  rate of 20 ml/h. C4-bp eluted as a  heterogeneous peak  (A, B, 
C). Fractions 65, 70, 75, 80, and the pooled 70-80 fractions were analyzed by 0.1% SDS, 3%/ 
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~nents:  (a) incubation with Sepharose-4B beads coupled either to pure human 
C4b or  bovine serum  albumin  as  a  control.  The  beads were  washed  several 
times  with  0.01  M  Tris,  0.025  M  NaC1,  pH  8.6,  then  eluted  with  a  solution 
containing  2%  SDS and  6  M  urea.  The eluates were subjected to SDS-PAGE 
under nonreducing  and reducing conditions with 2-mercaptoethanol;  (b) incu- 
bation  with  antiserum  to  C4-bp or with  normal  rabbit  serum.  The  immune 
complexes were removed from solution with formaldehyde-treated Staphylococ- 
cus A.  The  bacteria  were washed extensively and  treated  with  2%  SDS-6  M 
urea to elute and dissociate the antigen antibody complexes. Again, the eluates 
were  counted  and  subjected to  SDS-PAGE  under  nonreducing  and  reducing 
conditions. 
In both experiments between 55 and 60% of the counts were specifically bound 
to the particles. That the same material was involved in both cases was shown 
by cross  absorption  experiments;  less  than  5%  of the  counts  were  immune 
precipitated by the antiserum to C4-bp if the sample had been pretreated with 
an excess of Sepharose 4B-C4b. 
The proteins which bound to the beads were further identified after radioau- 
tography  of the  stained,  dried  SDS-PAGE  gels.  Before reduction  (left side of 
Fig. 5), the specific eluates obtained from both experiments contained only the 
two heavy bands shown in the starting  sample.  After reduction  (right  side of 
Fig. 5), a single specific band of mol wt 70,000 daltons was observed. The mol wt 
of the subunit of C4-bp was also determined in experiments in which mixtures 
of purified,  radiolabeled C4-bp and purified C4 were reduced and subjected to 
5.6% SDS-PAGE.  After staining the gels and radioautography,  we found that 
the C4-bp band coincided with that of the E-chain of C4, which has a tool wt of 
approximately 70,000 daltons. 
Properties of  Purified C4-Binding Protein.  C4-bp appears to be distinct from 
other known complement components and serum proteins.  It is present in the 
serum of patients with genetic deficiencies in C2, C4, C3b-inactivator,  or high 
molecular weight kininogen.  C4-bp did not react with monospecific antisera to 
the  following serum  proteins:  Clq,  Clr,  Cls,  C4,  C3,  Cl-inhibitor,  ~IH,  C3b- 
inactivator,  a-2 macroglobulin, and high molecular weight kininogen. 
The nature of the structural differences between the two bands of C4-bp is not 
known. Both bands stain heavily with the periodic acid-Schiff reagent, suggest- 
ing high contents of carbohydrate. As mentioned, after complete reduction in 2- 
mercaptoethanol  and 6 M urea,  a  single polypeptide chain of 70,000 daltons is 
seen in SDS-PAGE (Fig. 5). The mol wt of the two major bands before reduction 
were calculated to be 590,000 and 540,000 daltons,  using as standards oligomers 
of rabbit IgG and  human  IgM  (Fig.  6),  or BSA oligomers  (not shown).  From 
these data we infer that  C4-bp consists of several disulfide bonded protomers 
(perhaps eight) of 70,000 daltons. 
By sucrose gradient ultracentrifugation,  purified C4-bp sedimented at 10.7 s. 
To compare in a more rigorous fashion the sedimentation coefficients of purified 
C4-bp and serum C4-bp, the purified protein was radiolabeled and 2  /zg were 
added to 0.2 ml of serum from a patient genetically deficient in C4. The mixture 
was subjected to ultracentrifugation  and the fractions monitored for radioactiv- 
ity and for C4-bp antigen by RIE. As shown in Fig. 7 A the peak of radiolabeled J.  SCHARFSTEIN,  A.  FERREIRA,  I.  GIGLI,  AND  V.  NUSSENZWEIG  215 
FIG.  5.  Identification by immunological and functional criteria of C4-bp after electropho- 
resis on SDS-PAGE.  Fractions  70-80 from  Biorex chromatography were  pooled,  concen- 
trated,  and  radiolabeled.  The  specific  activity was  2  ×  10  e cpm/#g protein.  C4-bp was 
identified both by immunoprecipitation and affinity chromatography. For immunoprecipi- 
tation, 3  ×  106 cpm of 125I-C4-bp in Tris buffer 0.01 M, pH 8.6 containing 0.025 M NaCl and 
1 mg/ml BSA were mixed with increasing volumes of antiserum to C4-bp (1, 2, 4, 8,  16, and 
32  /~l) or with normal rabbit serum.  50  #1 of a  10% suspension of Staphylococcus A  were 
added  to  each  reaction  mixture  and  incubated for  20  rain  at  room  temperature.  After 
centrifugation at 2,000 g  for 20 min, the pellets were washed several times. After counting 
the washed pellets, 150 ~1 of 2% SDS-6 M urea were added and the bacteria suspension was 
heated for 3 min in boiling water vapors. After spinning down at 2,000 g  for 20 min, the 
supernate  was  removed,  counted,  and  recoveries estimated.  A  maximum  of 55%  of the 
labeled  material  was  specifically  immunoprecipitated.  The  eluates  were  subsequently 
loaded in SDS-PAGE slabs under nonreducing conditions, or after reduction with 20% ~-2 
mercaptoethanol. After electrophoresis the gels were stained, dried, and radioautographed. 
The figure (left to right) illustrates that both major bands on the partially purified 125I C4- 
bp are specifically recognized by anti-C4-bp. After reduction (right part of the figure) and 
electrophoresis,  a  single polypeptide chain of 70,000 daltons is obtained.  The C4-bp band 
was functionally identified by incubating 6 x  l0  b cpm of 125I-C4-bp with increasing amounts 
of pelleted Sepharose 4B-C4b or Sepharose 4B-BSA. After several washes with 0.01 M Tris, 
0.025  M  NaCl  pH 8.6,  the labeled material was eluted from the beads with 2% SDS-6 M 
urea. 60% of the label was specifically bound to the beads. Analysis of the eluates on SDS- 
PAGE gels under nonreducing or reducing conditions is illustrated.  Again the two major 
bands of the C4-bp preparation bound specifically to Sepharose 4B-C4b and after reduction, 
a  single polypeptide chain of 70,000  was obtained.  The markers on the right side of the 
figure were included in the 7.5% gels only. 216  HUMAN  C4-BINDING  PROTEIN 
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Fro.  6.  Estimation of the molecular weight of C4-bp by SDS-PAGE.  Molecular weights 
were measured by disc gel electrophoresis according to the method of Weber and Osborn 
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and 3.5% polyacrylamide, r 2 =  0.99, P  <  0.01. 
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FIG.  7.  Comparison of purified C4-bp and C4-bp in C4-deficient (C4D) serum by sucrose 
gradient ultracentrifugation.  12sI-C4-bp (10/~1, containing about 2/~g protein and 3  x  106 
cpm) were mixed with 0.4 ml of C4D serum. 0.15 ml of this mixture was incubated at 37°C 
for 10 min with either (A) 0.15 ml of 0.01 M Tris, 0.025 M NaC1, pH 8.6, or (B) 0.15 ml of 
purified C4b (0.7 mg/ml) in the same buffer. 0.2 ml of each mixture was loaded on top of 5 
ml 10-40% sucrose gradients and ultracentrifuged at 38,000 rpm for 20 h. The sedimentation 
coefficient of C4-bp was calculated as 10.7 S using known proteins as standards. (r 2 =  0.996, 
P  <  0.01). The standard proteins were added to C4-bp before the run and their positions in 
the gradient after centrifugation were determined by RIE. 
purified C4-bp coincided precisely with that of C4-bp from serum. Furthermore, 
the addition of purified C4b to the C4D-serum  (Fig.  7 B) resulted in a parallel 
displacement of both peaks to the bottom of the gradient  (15.3 s). 
In Fig.  8 we demonstrate  that C4-bp,  purified  (top, right) or in C4D-serum 
(bottom, right) moves in electrophoresis as a slow/3-globulin in barbital-EDTA 
buffer.  In buffer containing  Ca++-lactate,  C4-bp moves  as  a  gamma  globulin 
(not shown). A marked shift in its mobility is caused by addition of purified C4b J.  SCHARFSTEIN~  A.  FERREIRA~  I.  GIGLI~  AND  V.  NUSSENZWEIG  217 
FIG.  8.  Anodic shift of purified C4-bp after interaction with purified C4b.  Purified C4-bp 
and  C4-bp  in  C4D  serum  migrate  as  slow  fl-globulins  (right,  top  and  bottom).  Upon 
incubation  with purified C4b,  serum C4-bp and  purified C4-bp shifted toward  the anode 
(left,  top,  and  bottom).  Top  right,  C4-bp  purified  120  ~g/ml; bottom  right,  C4D  serum 
diluted 1:4; top left, C4-bp purified,  120  /~g/ml +  C4b,  200  /~g/ml; bottom left, C4D serum 
diluted  1:4  +  C4b,  200  /~g/ml.  The  diluent  was  barbital-EDTA.  The  mixtures  were 
incubated  at 37°C for 1 h  and 5  /~1 of each sample was subjected to CIE. Transferrin was 
added to the mixtures containing purified C4 and C4-bp. The slides were developed with a 
mixture of antisera to C4-bp and to transferrin (internal marker). 
(top and bottom, lei~).  The new position of C4-bp coincides with that of C4-bp in 
normal human serum (compare Figs.  1 and 8).  Furthermore, the formation of 
complexes between purified C4-bp and C4b, was shown by a combination of RIE 
and CIE,  as described  in Fig.  2; antisera to C4 completely precipitated  C4-bp 
in the mixtures (not shown). 
Stoichiometry  of the  C4b/C4-bp  Interaction.  The  formation  of  C4/C4-bp 
complexes using purified proteins can be easily detected by CIE.  As shown in 
Fig.  8, C4-bp, which is a slow fl-globulin, moves much faster toward the anode 218  HUMAN  C4-BINDING  PROTEIN 
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FIG.  9.  Purified C4-bp rocket heights vary according to the concentration of C4b added to 
the samples. Aliquots of purified C4-bp (50 ~l, containing 12.2/~g of purified protein) were 
mixed with 100/~l of barbital-EDTA containing increasing concentrations of purified C4b. 
The mixtures were incubated for 1 h at 37°C and analyzed for either C4-bp or C4 antigen by 
RIE. The bottom graph (B) illustrates that rocket heights of C4-bp are strongly influenced 
by the concentration of C4b in a given sample.  Graph A  (top) shows that the C4b rockets 
are not affected by the interaction with C4-bp. An absorption coefficient value ofE;~&m  =  1 
for C4-bp at a concentration of 1 mg/ml was assumed. 
after interaction with C4b.  Furthermore, complex formation leads to a marked 
increase in the heights of C4-bp rockets obtained after CIE or RIE. For example, 
in Fig. 8 the area of bound C4-bp is much greater than the area of C4-bp alone. 
The differences in the properties between free and bound C4-bp can be used to 
estimate the stoichiometry of its reaction with C4b. In the experiment shown in 
Fig. 9 B, increasing amounts of C4b were added to a constant amount of C4-bp. 
The mixtures were incubated at 37°C for 60 min and then subjected to RIE. As 
illustrated,  the  heights  of the  rockets  increased  gradually  and  reached  a 
plateau. The amount of C4b necessary for maximum rocket heights was found 
to be equal to the amount needed for a complete shift in the position of the C4- 
bp peak after CIE. This amount of C4b probably saturates all sites of C4-bp.  If 
we  assume the  mol wt  of C4b  and  C4-bp  to be  190,000 and  560,000 daltons, 
respectively,  and  the  extinction coefficient for  C4-bp  at  1  mg/ml  to  be  1.0, 
saturation is reached at a ratio 4.8 molecules of C4b per molecule of C4-bp. 
The increase in the height of the C4-bp rockets upon complex formation with 
C4b reflects a modification of the antigenic determinants of C4-bp as recognized 
by the antiserum used in this experiment.  Part of the determinants of C4-bp 
may have been  covered by C4b,  and  in  addition new determinants exposed, J.  SCHARFSTEIN,  A.  FERREIRA,  I.  GIGLI,  AND  V.  NUSSENZWEIG  219 
since this antiserum was obtained by immunization with C4b/C4-bp complexes 
(see Materials and Methods). 
When C4 antigen was measured by RIE, the results obtained varied according 
to the antisera used. With some antisera, the heights of rockets were greatly 
changed after complex formation with C4-bp. In other cases (Fig. 9 A) very little 
or no change was observed. 
These findings highlight one possible  pitfall in the measurement by immu- 
nological methods of the concentration of proteins which form complexes with 
other  molecules.  Because  of these  difficulties,  we  could  not  calculate  the 
recoveries and specific activities of C4-bp during the purification procedure, nor 
could we determine its levels in human serum. 
Discussion 
In this paper we describe the isolation and characterization of a  protein in 
human serum which displays specific binding affinity for the activated form of 
C4  (C4b). This  protein,  named  C4-bp, differs from  all  known  complement 
components. 
C4-bp was purified from plasma by PEG precipitation, followed by sequential 
ion-exchange chromatography. The recovery and specific activity of C4-bp after 
fractionation could not be calculated, for the reasons described in the Results 
section. 
Purified C4-binding protein is a 10.7 s glycoprotein. It migrates as a slow ~- 
globulin after agarose electrophoresis in barbital-EDTA buffer. However, when 
electrophoresis  is  performed in  the  presence  of Ca-lactate,  purified  C4-bp 
migrates as  a  gamma globulin.  Its  apparent mol wt on  SDS-PAGE  is  540- 
590,000 daltons. It consists of several identical subunits of 70,000 daltons linked 
by disulfide bonds. 
Analysis of the purified preparation by SDS-PAGE revealed the presence of 
two  major bands  and two  minor contaminants.  The two  major bands  were 
identified as C4-bp by functional and immunological criteria: both forms of C4- 
bp bound specifically to Sepharose 4B-C4b, and were immunoprecipitated by 
monospecific antisera.  The  small  difference in  molecular weight of the  two 
forms of C4-bp is probably not artefactual, and reflects a true heterogeneity. 
For example, although both bands were detected in peaks B and C obtained 
after chromatography on Biorex-70  (Fig.  4),  the high mol wt C4-bp predomi- 
nated  in  peak  B,  while  the  lower  mol  wt  form  predominated in  C.  This 
observation suggests that these two forms of C4-bp have slightly different net 
electric charges at pH 7.2. The reason for this heterogeneity is unknown. Gross 
denaturation as a consequence of the purification procedure is unlikely since 
the purified material retained all properties of C4-bp in serum. The two forms of 
C4-bp may represent structural variants, since these are detected even after a 
single-step (euglobulin) serum fractionation. The precise nature of this varia- 
tion remains to be elucidated. 
Purified C4-bp binds  to  purified C4b. Complex formation did  not require 
additional co-factors and was directly demonstrated by ultracentrifugation in 
sucrose gradients (Fig.  7) and by CIE. During electrophoresis in agarose at pH 220  HUMAN  C4-BINDING  PROTEIN 
8.6, the complexes moved faster toward the anode than C4-bp alone (Fig. 8) and 
could be coprecipitated by an antiserum specific for C4. 
Complexes formed in the presence of diisopropylfluorophosphate (10  -~ M) or 
EDTA (10  .2 M). Similarly, as previously reported, the binding of mouse C4-bp 
to human C4b could not be inhibited by DFP, soy bean trypsin inhibitor, ovo- 
mucoid, or by chelation of divalent cations (8). 
Based on the progressive shift in the electrophoretic mobility of C4-bp,  as 
well as on the parallel changes in its antigenic determinants after interaction 
with C4b, we could evaluate the stoichiometry of the reaction. We found that 
C4-bp molecules are multivalent and each can bind a maximum of four to five 
molecules of C4b. However, precise determination of the valence of C4-bp and of 
the  stoichiometric  relationships,  must  await  accurate  measurement  of the 
molecular weight of C4-bp. 
The data presented in this paper may be helpful in clarifying the conflicting 
results presented in the literature on the electrophoretic mobility patterns of C4 
in serum and EDTA-plasma.  In agreement with SjSholm and Laurell (23), we 
found that during electrophoretic runs of serum in agarose containing media, 
the complement system is activated, probably due to C1 conversion to Ci (24). 
This  activation leads to  fragmentation of C4 to  C4b,  and complex formation 
with C4-bp. As shown, these complexes display altered electrophoretic mobility 
as compared to free C4b and C4-bp. Therefore, at least three bands containing 
C4 antigen may be formed; that is, native C4, C4b, and C4b/C4-bp complexes. If 
the complexes contain different ratios of C4b to C4-bp,  the situation  may be 
even more complex. In contrast, in EDTA-plasma, C1 activation is prevented 
and stable complexes are not formed. 
Recently, Teisberg et al.  (5) have reported data on the genetic polymorphism 
of C4, using samples of blood collected in heparin. We found that the formation 
of C4/C4-bp  complexes  after electrophoresis  in  agarose  is  prevented by  the 
addition of 25 U or more of heparin/ml of blood. When smaller doses are used, 
stable complexes may still form. 
The role of C4-bp in the complement cascade and in modulating C4 activity 
will be the subject of a separate communication. 
Summary 
C4-binding protein (C4-bp),  a new component of the complement system, was 
isolated from human plasma by precipitation with polyethyleneglycol, followed 
by chromatography on ion exchangers. C4-bp was identified on sodium dodecyl- 
sulfate  polyacrylamide gel  electrophoresis  (SDS-PAGE)  by two  independent 
criteria: its ability to bind to C4b, and immunoprecipitation with a monospecific 
antiserum. 
Purified C4-bp is a  10.7 s glycoprotein. It consists of several disulfide bonded 
subunits of mol wt 70,000 daltons. Under nonreducing conditions, its mol wt has 
been estimated on SDS-PAGE as 540-590,000  daltons. 
C4-bp moves as a  slow B-globulin at pH 8.6  in the absence of free divalent 
cations, but when the buffers contain Ca++-lactate, C4-bp is a gamma globulin. 
Purified C4-bp binds to purified C4b. The reaction proceeds in the presence or 
absence of divalent cations and is not inhibited by diisopropylfluorophosphate. J.  SCHARFSTEIN,  A.  FERREIRA~  I.  GIGLI~  AND  V.  NUSSENZWEIG  221 
The C4b/C4-bp complexes have sedimentation coefficients between 15 and 17 s 
on sucrose gradient ultracentrifugation, and can be readily identified by crossed 
immunoelectrophoresis  (CIE).  The  complexes  move  faster  toward  the  anode 
than either protein. 
C4-bp is multivalent.  Saturation is reached at molecular ratios of C4b/C4-bp 
of between 4 and 5. 
The interaction between C4b and C4-bp may complicate the electrophoretic 
patterns of these proteins in normal human serum, if the complement system is 
activated before or during the run.  However, in EDTA-plasma,  native C4 and 
C4-bp  do not  form stable  complexes and  can  be  identified  in  separate  peaks 
after CIE. 
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